Related Experiment Videos
[Trial of piracetam in children with cerebral organic mental deficiency]
Insights
Piracetam administration to brain-injured children did not improve learning or behavior. A double-blind study found no lasting cognitive or behavioral benefits from piracetam in special education students.
Area of Science:
- Neuroscience
- Pediatric Neurology
- Special Education
Background:
- Brain-injured children often exhibit deficits in cognitive abilities and behavior.
- Piracetam is a nootropic agent sometimes explored for cognitive enhancement.
- Special education settings serve children with diverse learning needs.
Purpose of the Study:
- To evaluate the efficacy of piracetam in improving cognitive functions and behavior in brain-injured special education children.
- To assess the impact of piracetam on learning capacity, concentration, proficiency, and behavior.
Main Methods:
- A double-blind, placebo-controlled experiment was conducted.
- Two homogeneous groups of 8-12-year-old children with brain injuries participated.
- Piracetam was administered daily for thirteen weeks at doses of 1.2 g or 2.0 g.
Main Results:
- Piracetam did not produce lasting improvements in the capacity to acquire and apply knowledge.
- No significant effects were observed on concentration power, proficiency level, or behavior.
- A nonsignificant tendency toward improved physical well-being was noted in the placebo group.
Conclusions:
- Piracetam administration showed no lasting cognitive or behavioral benefits in this cohort.
- The study suggests a potential negative effect of piracetam compared to placebo.
- Further research may be needed to explore alternative interventions for this population.
Abstract:
The administration, in a double blind experiment, of piracetam to two homogeneous groups of 32 and 34 eight- to twelve-year-old brain-injured special education children lacking normal mental ability, where the daily doses administered for a period of thirteen weeks were 3 tablets or 1.2 g (administered to second and third graders) and 5 tablets or 2.0 g (administered to fourth graders), respectively, did not produce a lasting effect upon the capacity to acquire and apply knowledge, the concentration power, the proficiency level, and the behavior shown by pupils during and out of school hours. On the other hand, there was observed, in patients receiving placebos, a nonsignificant tendency toward improvement in physical well-being, so that the effect produced by the drug may here be considered to be a negative one.